BioPharma, Daily, MedCity Influencers, Pharma, Policy

Targeted and succinct information concerning the world of pharmaceutical

Clinical development and manufacture of large molecule drugs news and analysis

Experienced associate editor focused on biopharmaceutical industry content.

Biopharma and digital health topics for Fast Company, Inc, Fortune

Science, pharma, and medtech focus in pharmaceutical industry coverage

Large drugmakers and pharmaceutical industry coverage

Healthcare, pharma, biotech, biopharma, medtech, digital health topics

Biotech, pharma and medtech reporting and coverage

Pharma and healthtech news and content management

MedTech, medical news, and health technology topics

Pharma intelligence and healthcare industry content and analysis

Biopharma coverage and reporting focused on industry developments

Pharmaceutical industry content focusing on executive and commerce aspects

Healthcare coverage focused on pharma industry

Health care journalism with focus on pharmaceutical industry and news

Biotech and pharma data journalism

Pharma and biotech business and life sciences coverage

Future of biotech and pharmaceutical industries

Pharma and health topics, awarded for journalistic excellence

Biotech, pharma, and health innovation coverage

Biopharma, precision oncology, healthcare, and science content development

Environmental reporter and assistant editor with experience covering U.S. pharmaceutical and biotechnology drug companies. Skilled in editorial roles and industry analysis.

Biopharma industry and technology content focused on healthcare and life sciences

Senior editor focused on news and analysis in the life sciences sector

News and analysis articles, interviews, expert communication in healthcare

Pharmaceutical industry content and program contributions

Staff writer covering pharmaceutical industry news and developments for a specialized media outlet.

Biopharma and medtech reporting focused on related industry developments

Oncology and biotech industry content focused on pipeline developments

FDA, Capitol Hill, biotech and pharma coverage